Skip to main content
Clinical Trials/NL-OMON25226
NL-OMON25226
Recruiting
N/A

A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home

MC Utrecht0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
MC Utrecht
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
MC Utrecht

Eligibility Criteria

Inclusion Criteria

  • 1\) Age \=40 years
  • 2\) Cardiovasculair risk profile or cardiovascular disease (overweight, hypertension, diabetes, smoking, coronary artery disease, previous myocardial infarction, heart failure)
  • 3\) Presumably COVID\-19 (both SARS\-CoV\-2 positive and non\-COVID\-19 confirmed patients)
  • 4\) Moderate\-severe symptoms
  • 5\) Mentally competent

Exclusion Criteria

  • 1\) Severe illness requiring hospital admission
  • 2\) Patient does not want future hospitalisation
  • 3\) Known anemia
  • 4\) Inadequate mastery of the Dutch language
  • 5\) Not willing to sign informed consent
  • 6\) Not willing to adhere to study procedures

Outcomes

Primary Outcomes

Not specified

Similar Trials